Zealand Pharma A/S reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was DKK 15.09 million compared to DKK 13.63 million a year ago. Net loss was DKK 228.65 million compared to DKK 193.63 million a year ago.

Basic loss per share from continuing operations was DKK 3.71 compared to DKK 3.76 a year ago.